Processa Pharmaceuticals Inc (PCSA)
US$ 1.1-4.35%
Price Chart
Key Statistics
Market Cap
$ 9.31M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
26.13K
52W High
$ 1.90
52W Low
$ 0.15
Dividend Yield
0.00%
Beta
1.31
Technicals
50-Day MA
0.2519
200-Day MA
0.5872
52 Week High
1.9
52 Week Low
0.15
About PCSA
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
Employees
10
Headquarters
Hanover, MD
CEO
Mr. George K. Ng Esq., J.D.